- Report
- February 2024
- 188 Pages
Global
From €4542EUR$4,900USD£3,815GBP
- Report
- November 2023
- 190 Pages
Global
From €4542EUR$4,900USD£3,815GBP
- Report
- October 2023
- 184 Pages
Global
From €4542EUR$4,900USD£3,815GBP
- Report
- October 2023
- 177 Pages
Global
From €4542EUR$4,900USD£3,815GBP
- Report
- October 2023
- 188 Pages
Global
From €4542EUR$4,900USD£3,815GBP
- Report
- October 2023
- 190 Pages
Global
From €4542EUR$4,900USD£3,815GBP
- Report
- November 2023
- 209 Pages
Global
From €4218EUR$4,550USD£3,542GBP
- Report
- November 2023
- 178 Pages
Global
From €4542EUR$4,900USD£3,815GBP
- Report
- November 2023
- 178 Pages
Global
From €4542EUR$4,900USD£3,815GBP
- Drug Pipelines
- August 2024
- 60 Pages
Global
From €1159EUR$1,250USD£973GBP
- Report
- July 2024
- 100 Pages
Global
From €3476EUR$3,750USD£2,920GBP
- Drug Pipelines
- July 2024
- 240 Pages
Global
From €2317EUR$2,500USD£1,946GBP
- Drug Pipelines
- July 2024
- 240 Pages
Global
From €2781EUR$3,000USD£2,336GBP
- Clinical Trials
- June 2024
- 180 Pages
Global
From €2317EUR$2,500USD£1,946GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1159EUR$1,250USD£973GBP
- Clinical Trials
- April 2024
- 550 Pages
Global
From €4635EUR$5,000USD£3,893GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1854EUR$2,000USD£1,557GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1854EUR$2,000USD£1,557GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2781EUR$3,000USD£2,336GBP
- Clinical Trials
- April 2024
- 240 Pages
Global
From €2781EUR$3,000USD£2,336GBP
T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more